166 related articles for article (PubMed ID: 37732549)
1. Britanin inhibits titanium wear particle‑induced osteolysis and osteoclastogenesis.
Kim JA; Lim S; Ihn HJ; Kim JE; Yea K; Moon J; Choi H; Park EK
Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37732549
[TBL] [Abstract][Full Text] [Related]
2. Pentamidine Inhibits Titanium Particle-Induced Osteolysis
Ihn HJ; Kim K; Cho HS; Park EK
Tissue Eng Regen Med; 2019 Jun; 16(3):265-273. PubMed ID: 31205855
[TBL] [Abstract][Full Text] [Related]
3. Rifampin suppresses osteoclastogenesis and titanium particle-induced osteolysis via modulating RANKL signaling pathways.
Zhu L; Kang H; Guo CA; Fan WS; Wang YM; Deng LF; Yan ZQ
Biochem Biophys Res Commun; 2017 Feb; 484(1):64-70. PubMed ID: 28108285
[TBL] [Abstract][Full Text] [Related]
4. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
[TBL] [Abstract][Full Text] [Related]
5. Arctigenin inhibits RANKL-induced osteoclastogenesis and hydroxyapatite resorption in vitro and prevents titanium particle-induced bone loss in vivo.
Wei G; Liang T; Wei C; Nong X; Lu Q; Zhao J
J Cell Biochem; 2019 Apr; 120(4):5367-5376. PubMed ID: 30317692
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of triptolide on titanium particle-induced osteolysis and receptor activator of nuclear factor-κB ligand-mediated osteoclast differentiation.
Kim JA; Ihn HJ; Park JY; Lim J; Hong JM; Kim SH; Kim SY; Shin HI; Park EK
Int Orthop; 2015 Jan; 39(1):173-82. PubMed ID: 25416122
[TBL] [Abstract][Full Text] [Related]
7. Tetrandrine Inhibits Titanium Particle-Induced Inflammatory Osteolysis through the Nuclear Factor-
Liu Z; Li Y; Guo F; Zhang C; Song G; Yang J; Chen D
Mediators Inflamm; 2020; 2020():1926947. PubMed ID: 33312069
[TBL] [Abstract][Full Text] [Related]
8. Titanium particle‑mediated osteoclastogenesis may be attenuated via bidirectional ephrin‑B2/eph‑B4 signaling in vitro.
Ge YW; Liu ZQ; Sun ZY; Yu DG; Feng K; Zhu ZA; Mao YQ
Int J Mol Med; 2018 Oct; 42(4):2031-2041. PubMed ID: 30015911
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of osteoclastogenesis for periprosthetic osteolysis therapy through the suppression of p38 signaling by fraxetin.
Liao JC; Wei ZX; Zhao C; Ma ZP; Cai DZ
Int J Mol Med; 2018 Sep; 42(3):1257-1264. PubMed ID: 29786751
[TBL] [Abstract][Full Text] [Related]
10. The prevention of titanium-particle-induced osteolysis by OA-14 through the suppression of the p38 signaling pathway and inhibition of osteoclastogenesis.
Tian B; Jiang T; Shao Z; Zhai Z; Li H; Fan Q; Liu X; Ouyang Z; Tang T; Jiang Q; Zheng M; Dai K; Qin A; Yu Y; Zhu Z
Biomaterials; 2014 Oct; 35(32):8937-50. PubMed ID: 25086794
[TBL] [Abstract][Full Text] [Related]
11. Piperlongumine Inhibits Titanium Particles-Induced Osteolysis, Osteoclast Formation, and RANKL-Induced Signaling Pathways.
Liu X; Diao L; Zhang Y; Yang X; Zhou J; Mao Y; Shi X; Zhao F; Liu M
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270008
[TBL] [Abstract][Full Text] [Related]
12. Scutellarin inhibits RANKL-mediated osteoclastogenesis and titanium particle-induced osteolysis via suppression of NF-κB and MAPK signaling pathway.
Zhao S; Sun Y; Li X; Wang J; Yan L; Zhang Z; Wang D; Dai J; He J; Wang S
Int Immunopharmacol; 2016 Nov; 40():458-465. PubMed ID: 27728897
[TBL] [Abstract][Full Text] [Related]
13. Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro.
Wu C; Wang W; Tian B; Liu X; Qu X; Zhai Z; Li H; Liu F; Fan Q; Tang T; Qin A; Zhu Z
Biochem Pharmacol; 2015 Jan; 93(1):59-71. PubMed ID: 25449599
[TBL] [Abstract][Full Text] [Related]
14. Melatonin suppresses Ti-particle-induced inflammatory osteolysis via activation of the Nrf2/Catalase signaling pathway.
Zhu X; Zhang Y; Yang H; He F; Lin J
Int Immunopharmacol; 2020 Nov; 88():106847. PubMed ID: 32771943
[TBL] [Abstract][Full Text] [Related]
15. Rhoifolin ameliorates titanium particle-stimulated osteolysis and attenuates osteoclastogenesis via RANKL-induced NF-κB and MAPK pathways.
Liao S; Song F; Feng W; Ding X; Yao J; Song H; Liu Y; Ma S; Wang Z; Lin X; Xu J; Zhao J; Liu Q
J Cell Physiol; 2019 Aug; 234(10):17600-17611. PubMed ID: 30854667
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of titanium-particle-induced inflammatory osteolysis after local administration of dopamine and suppression of osteoclastogenesis via D2-like receptor signaling pathway.
Yang H; Xu Y; Zhu M; Gu Y; Zhang W; Shao H; Wang Y; Ping Z; Hu X; Wang L; Geng D
Biomaterials; 2016 Feb; 80():1-10. PubMed ID: 26695376
[TBL] [Abstract][Full Text] [Related]
17. Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption.
Wang L; Guo X; Zhou W; Ding Y; Shi J; Wu X; Liu Y; Xu Y; Yang H; Geng D
Acta Biomater; 2018 Jun; 73():488-499. PubMed ID: 29656074
[TBL] [Abstract][Full Text] [Related]
18. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model.
Xiao F; Zhai Z; Jiang C; Liu X; Li H; Qu X; Ouyang Z; Fan Q; Tang T; Qin A; Gu D
Exp Cell Res; 2015 Jan; 330(1):91-101. PubMed ID: 25016282
[TBL] [Abstract][Full Text] [Related]
19. Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo.
Wei CM; Su YJ; Qin X; Ding JX; Liu Q; Song FM; Zong SH; Xu J; Zhou B; Zhao JM
Cell Physiol Biochem; 2018; 48(2):644-656. PubMed ID: 30025412
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of osteoclastogenesis by histone deacetylase inhibitor Quisinostat protects mice against titanium particle-induced bone loss.
Zhang L; Zhang L; You H; Sun S; Liao Z; Zhao G; Chen J
Eur J Pharmacol; 2021 Aug; 904():174176. PubMed ID: 34004213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
